Search

Search

Popular peptides

Which peptides are banned in sport?

If you can be drug tested under World Anti-Doping Agency rules, assume a peptide is banned until you’ve checked. BPC-157, TB-500 and the growth hormone boosters are banned by name, a catch-all rule covers almost anything no government has approved, and simply ordering one has cost an athlete three years.1

Updated · 103 sources

The short version

  1. The list names most popular peptides. Growth hormone and the peptides that raise it, IGF-1, TB-500 and BPC-157 are banned at all times, in and out of competition.2 The full list
  2. Unapproved usually means banned. A catch-all class, S0, bans any drug the list doesn’t otherwise cover if no government has approved it for human use.23 How S0 works
  3. Approved GLP-1 drugs aren’t banned. Semaglutide and tirzepatide are tracked, not banned. Retatrutide isn’t approved anywhere, so it likely falls under S0.456 GLP-1 drugs
  4. Check every product, every year. Search Global DRO or ask your anti-doping organization. A doctor’s prescription isn’t a defense, and the list changes each January.78 Every peptide on PepSavvy

How does WADA decide what’s banned?

It publishes one Prohibited List a year. The 2026 list took effect on January 1, 2026. Some things on it are banned at all times, others only in competition.

  • Three kinds of ban. Classes S0 to S5 and methods M1 to M3 are banned at all times. Classes S6 to S9, such as stimulants, are banned only in competition. Beta-blockers (P1) are banned only in particular sports.2
  • “In competition” starts the night before. It normally runs from 11:59 p.m. the day before an event the athlete is entered in until the event and its sample collection are over.2
  • The names are examples. Most classes list examples, then ban anything with a similar chemical structure or a similar effect. A peptide missing from the list isn’t automatically allowed.23
  • How things get added. A substance has to meet two of three tests: it can improve performance, it’s a real or potential health risk, or it breaks the spirit of sport.9
  • “Specified” doesn’t mean less serious. Some classes are marked “specified” because they’re more likely to be taken for reasons other than doping. That lets a tribunal cut a ban more easily, nothing more.2

Which peptides does WADA ban by name?

Growth hormone and almost every peptide sold to raise it, IGF-1, TB-500 and BPC-157, plus a few others such as MOTS-c and follistatin.

  • Growth hormone and its fragments. Class S2.2.3 bans growth hormone, its analogues and fragments, and names AOD-9604 and hGH 176-191.2
  • Peptides that release growth hormone. Class S2.2.4 names CJC-1295, sermorelin and tesamorelin; ipamorelin and ibutamoren (MK-677); and GHRP-2, GHRP-6 and hexarelin, listed as examorelin.2
  • Growth factors. Class S2.3 bans IGF-1 “and its analogues”, which covers IGF-1 LR3; mechano growth factors such as PEG-MGF; and thymosin beta-4 and its derivatives, naming TB-500.21011
  • Testosterone boosters, for men. Class S2.2.1 bans hCG, LH, gonadorelin and kisspeptin in male athletes.2 Testosterone itself is banned for everyone at all times (S1).2
  • Metabolic peptides. Class S4 names follistatin, which blocks myostatin, and the energy-sensor activators AICAR and MOTS-c. MOTS-c joined the list in 2025.212
  • BPC-157 is named too. It’s the one peptide the catch-all class S0 names, and has been since 2022.213
  • A prescription doesn’t change it. Growth hormone, tesamorelin (Egrifta), hCG and testosterone are FDA-approved drugs, and they’re still banned for athletes who don’t have an exemption.14151617

Why are unapproved peptides banned too?

Because of class S0, a catch-all that bans any drug the rest of the list doesn’t cover if no government anywhere has approved it for human use.

  • What S0 covers. Drugs still in development, discontinued drugs, designer drugs and drugs approved only for animals, as long as no other class covers them. Everything in it is banned at all times.2
  • Most research peptides fit. Peptides sold online “for research use only”, such as epitalon or dihexa, have no approval anywhere. WADA’s own guidance on substances it doesn’t name:3

“…has not been approved for human use is likely to be prohibited as well.”

World Anti-Doping AgencyOn substances the list doesn’t name3
  • Approval anywhere counts. A drug approved in just one country, such as Semax in Russia, glutathione in Italy or mazdutide in China, falls outside S0, though another class can still ban it.2181920
  • It’s decided case by case. WADA says it places substances in S0 only after evaluating each one, and that most banned substances fall into the named classes instead. So S0 status below is our reading of the rule, not a ruling.3
  • It gets stricter in 2027. From January 1, 2027, the S0 definition adds the word “peptides” to its examples, and WADA’s notes urge extreme caution with any peptide, named or not. Approved peptide drugs still aren’t covered.2122
  • USADA’s advice is simpler. Avoid any product labeled “research chemical”, “for research purposes only” or “not for human consumption”, even if no banned ingredient is listed.23

Are GLP-1 drugs like semaglutide banned?

No. WADA tracks semaglutide and tirzepatide but doesn’t ban them. Experimental GLP-1 drugs that no country has approved, such as retatrutide, likely fall under S0.

  • Tracked, not banned. Semaglutide has been on WADA’s Monitoring Program since 2024, and tirzepatide was added by name for 2026. The program counts how often athletes use a drug without banning it.424
  • Still allowed in 2027. WADA decided to leave GLP-1 drugs off the 2027 list while it gathers more data, and has started a second study of their effects in athletes.9
  • No exemption needed. USADA says athletes don’t need one for GLP-1 drugs. Its advice covers only FDA-approved products, and it warns that “research only” GLP-1 products are unapproved.5
  • Newly approved ones are allowed too. Orforglipron, the Foundayo pill FDA approved in April 2026, and mazdutide, approved in China, aren’t banned, and WADA doesn’t monitor either yet.4202526
  • Experimental ones are different. Lilly says retatrutide hasn’t been approved by any regulator, which fits S0’s wording. We found no WADA or USADA ruling on it.26

Are IV drips of NAD+ or vitamins banned?

The drip itself can be. More than 100 mL by IV in 12 hours breaks the rules whatever is in the bag, unless it’s given in a hospital, during surgery or for medical tests.

  • The 100 mL rule. Method M2.2 bans IV infusions or injections of more than 100 mL in total in any 12-hour period, except during hospital treatment, surgery or clinical tests.2
  • It applies to plain saline. In August 2026, a US track and field athlete got a six-month ban for a home IV of saline over 100 mL, although nothing in it was banned.27
  • A syringe is fine. An ordinary injection isn’t a banned method, as long as the substance is allowed and the total stays at or under 100 mL in 12 hours.3
  • The contents matter separately. NAD+, glutathione and L-carnitine aren’t banned substances, but a drip of any of them can still break the volume rule.2

Can an athlete get an exemption to use a banned peptide?

Sometimes, for an approved drug and a diagnosed medical need. For an unapproved peptide like BPC-157, USADA says an exemption is unlikely.

  • Four conditions, all required. A diagnosed condition backed by clinical evidence; the drug is an accepted treatment with no reasonable permitted alternative; it does no more than restore normal health; and the need wasn’t caused by earlier banned use.28
  • Where to apply. National-level athletes apply to their national anti-doping agency, and international-level athletes to their federation. In the US, athletes in USADA’s testing pools need an exemption before use; others can check with USADA and may get one afterwards.2930
  • Unapproved peptides are a long shot. No rule excludes them, but USADA says a BPC-157 exemption is unlikely because permitted alternatives exist.2831
  • College athletes. The NCAA has its own banned list and requires pre-approval for a medical exception. USADA and the NCAA don’t recognize each other’s exemptions.3032

What happens if an athlete is caught using peptides?

Usually a ban: two years by default for BPC-157 and four years for most growth hormone peptides, before any reductions. It doesn’t take a positive test.

  • Two to four years, by default. Two years for a “specified” substance such as BPC-157, and four years for using or having non-specified ones such as TB-500, CJC-1295 or ipamorelin. Prompt admissions and cooperation can reduce them.3334
  • Ordering can be enough. Possession and attempted use are violations too, even when a package never arrives.1

Peptide bans in USADA and court cases

  1. Feb 2026 · Masters weightlifting

    Ipamorelin and ibutamoren (MK-677): a positive test, plus admitted use and possession. Ban: 3 years.35

  2. Sep 2025 · Triathlon

    BPC-157 and TB-500 use and possession, plus promoting CJC-1295, ipamorelin and tesamorelin on social media. Ban: 4 years.34

  3. Oct 2024 · Snowboarding

    IGF-1 ordered online. A parent intercepted the package, but ordering it counted as possession and attempted use. Ban: 3 years.1

  4. Aug 2024 · Speedskating

    BPC-157 in a supplement a medical provider recommended. Admitted use, no positive test. Ban: 1 year.33

  5. Sep 2023 · Mixed martial arts

    BPC-157 prescribed by a doctor and self-reported. USADA said an exemption didn’t apply to an unapproved substance. Ban: 4 months.8

  6. Jan 2021 · Mixed martial arts

    AOD-9604 and 7-keto-DHEA prescribed by a doctor and self-reported. Ban: 6 months.36

  7. Jan 2021 · Weightlifting

    IGF-1, GHRP-2, GHRP-6 and CJC-1295 bought from an online peptide store. Ban: 4 years.37

  8. Jul 2020 · Mixed martial arts

    GHRP-6 found in an out-of-competition test. Ban: 2 years.38

  9. Dec 2017 · Track and field

    AICAR from a vial labeled not for human consumption. No positive test. Ban: 4 years.39

  10. Apr 2016 · Mixed martial arts

    Ibutamoren (MK-677) from a contaminated supplement. Ban: 6 months.40

  11. Jan 2016 · Australian football

    Thymosin beta-4: the Court of Arbitration for Sport banned 34 current and former Essendon players. Ban: 2 years each.4142

How can an athlete check whether a peptide is banned?

Search Global DRO or ask your anti-doping organization, and treat anything sold “for research use only” as banned unless you’re told otherwise.

  • Start with Global DRO. It’s a free lookup of medicines sold in the US, Canada, the UK, Switzerland, Japan, Australia and New Zealand, run by USADA and other national agencies. It doesn’t cover supplements.7
  • Not every peptide is in it. USADA warns that banned peptides are often sold under other names or slang, so a missing entry proves nothing.43
  • Creams count too. A banned peptide is banned however it’s used, though small amounts on unbroken skin are unlikely to cause a positive test. Most peptides in skin products aren’t banned.344
  • College and the military have their own lists. The NCAA’s 2026–27 list bans peptide hormones, naming BPC-157, MK-677 and TB-500. The Department of Defense bans BPC-157, TB-500 and most growth hormone peptides as supplement ingredients for service members.454647
  • The list changes every January. The 2027 list, already published, takes effect on January 1, 2027. It adds SLU-PP-332 and SLU-PP-915 by name.2122

Which peptides on PepSavvy are banned in sport?

Of the 70 peptides, compounds and blends with profiles here, 26 are named on WADA’s list or fall in a class it names, 22 are likely banned because no government has approved them, 3 have no ruling either way, and 19 aren’t banned as substances.

Where every PepSavvy profile stands under WADA’s 2026 list
  • Banned by name or class: 26
  • Likely banned under S0: 22
  • Unclear: no ruling either way: 3
  • Not banned as a substance: 19

Each square is one profile. Blends take the strictest status of their parts.2

This is our reading of WADA’s 2026 list. Only an anti-doping organization can rule on a product, so check before you use anything.

Banned by name or class · 26

  • AOD-9604S2.2.3

    Named in S2.2.3 as a growth hormone fragment. A UFC fighter who reported using AOD-9604 a doctor had prescribed got a six-month ban in 2021.23643

  • ARA 290S2.1.5

    Not named, but ARA 290 (cibinetide) acts on the innate repair receptor, the class S2.1.5 bans, and doping-control researchers in Cologne call it prohibited.24849505152

  • BPC-157S0

    The only peptide S0 names, since 2022. It’s approved nowhere, and USADA says an exemption is unlikely.21331

  • Bromantane (Ladasten)S6.AIn competition only

    Named as “bromantan” among the stimulants, so it’s banned in competition only.2

  • CJC-1295 (no DAC)S2.2.4

    Sold under the listed name CJC-1295. Without the DAC part it’s still a GHRH analogue, a class S2.2.4 bans, so it’s banned either way.21153

  • CJC-1295 (no DAC) / Ipamorelin ProtocolS2.2.4

    Ipamorelin is named in S2.2.4 and the CJC-1295 part is a GHRH analogue in the same class, so the combination is banned at all times.23553

  • CJC-1295 with DACS2.2.4

    Named in S2.2.4 as a GHRH analogue, and it has come up in several USADA bans.23754

  • GHRP-6S2.2.4

    Named in S2.2.4 as a growth hormone–releasing peptide. A UFC fighter’s positive test for it led to a two-year ban in 2020.2373854

  • GLOWS0; S2.3

    Contains BPC-157 (S0) and TB-500 (S2.3), both named, so the blend is banned at all times whatever GHK-Cu’s status.243

  • HCGS2.2.1Men only

    Named in S2.2.1, which applies only to male athletes. It’s an approved prescription drug, so men would need an exemption.216

  • HexarelinS2.2.4

    Named in S2.2.4 under its official name, examorelin, with hexarelin in brackets.2

  • HGH / somatropinS2.2.3

    Named in S2.2.3 and banned at all times. Somatropin is an approved prescription drug, so an exemption is possible, but only for a diagnosed medical need that meets all four conditions.21455

  • IGF-1 LR3S2.3

    Not named, but the list bans IGF-1 “and its analogues,” and LR3 is a lab-made IGF-1 analogue. The Defense Department’s list files it under WADA’s S2.2101146

  • IpamorelinS2.2.4

    Named in S2.2.4 as a growth hormone secretagogue, and it appears in USADA cases from 2017 to 2026.23556

  • KisspeptinS2.2.1Men only

    Kisspeptin and drugs that mimic it have been named in S2.2.1 since 2024, a section that applies only to male athletes.257

  • KLOWS0; S2.3

    Contains BPC-157 (S0) and TB-500 (S2.3), both named, so the blend is banned at all times whatever the status of its other parts.243

  • MK-677 / ibutamorenS2.2.4

    Named in S2.2.4 as a growth hormone secretagogue, an example on the list since 2024.23557

  • MOTS-cS4.4.1

    Named in S4.4.1 as an AMPK activator since the 2025 list.212

  • PEG-MGFS2.3

    Mechano growth factors are named in S2.3, and PEG-MGF is a modified MGF. USADA lists MGF as “prohibited at all times.”21158

  • SermorelinS2.2.4

    Named in S2.2.4 as a GHRH analogue. Its FDA-approved version, Geref, is discontinued, though FDA found that wasn’t for safety or effectiveness reasons.259

  • TB-500S2.3

    Named in S2.3 as a thymosin beta-4 derivative. It isn’t a “specified” substance, so the default ban is four years.23443

  • TesamorelinS2.2.4

    Named in S2.2.4 even though it’s FDA-approved as Egrifta, so an athlete would need an exemption.215

  • TesofensineS6.BIn competition only

    Named as a stimulant in S6.B, so it’s banned in competition, from 11:59 p.m. the day before an event until the event ends. Because it’s a “specified” substance, a positive test is presumed unintentional if the athlete shows it was used out of competition.22160616263

  • Thymosin beta-4S2.3

    Named in S2.3. It was at the center of the 2016 case in which 34 Essendon Australian football players were banned for two years.24142

  • TRTS1.1

    Testosterone is named in S1.1 and banned at all times. Prescribed TRT needs an exemption that meets all four conditions.21728

  • Wolverine StackS0; S2.3

    Both parts are named: BPC-157 in S0 and TB-500 in S2.3. A triathlete who used the pair got a four-year USADA ban in 2025 that also covered promoting peptides online.234

Likely banned under S0 · 22

  • 5-Amino-1MQS0

    A research chemical with no approval and no registered human trials, so S0 bans it at all times even though WADA doesn’t name it.218256465

  • AdalankS0

    A chemically modified Selank. Approval covers only the exact registered substance, so Selank’s Russian registration doesn’t extend to it and S0 applies.218256465

  • AdamaxS0

    A research analogue of Semax with no approval anywhere, so S0 applies.218256465

  • AdipotideS0

    An experimental fat-targeting peptide whose only trial was stopped at phase 1, so it’s an unapproved S0 substance.218256466

  • CagrilintideS0

    An experimental amylin drug with no approval anywhere yet, which matches S0’s “drugs under clinical development.” A US decision on CagriSema, which contains it, is expected late in 2026; approval would take it out of S0.2318256467

  • CartalaxS0

    Registered in Russia only as a dietary supplement, not a medicine, so it has no approval as a drug and meets the S0 definition.218256468

  • DihexaS0

    An unapproved research compound, so S0 bans it at all times. The main argument that it falls under S2.3 as an HGF modulator rests on a paper retracted in 2025.225646569

  • EloralintideS0

    An experimental Lilly obesity drug in phase 3, which is exactly what S0 calls a “drug under clinical development.” No anti-doping body has named it.218256470

  • EpitalonS0

    No regulator anywhere has approved epitalon, so it’s an S0 substance, banned at all times. An FDA compounding review isn’t an approval.218687172

  • FOXO4-DRIS0

    An early-stage lab peptide with no approval or registered human trials, so it’s an S0 substance.218256465

  • KPVS0

    An unapproved fragment of alpha-MSH, so it’s an S0 substance. FDA’s 2026 review of KPV for compounding isn’t a drug approval.225647273

  • LL-37S0

    The body makes LL-37, but no regulator has approved it as a drug, so injecting it falls under S0.218256474

  • Melanotan IIS0

    No regulator has approved Melanotan II, which is still in trials, so it’s an S0 substance, banned at all times.218256475

  • NA Semax AmidateS0

    The N-acetyl, amidated version is a different molecule from Russia’s approved Semax and has no approval of its own, so S0 applies.218256465

  • P21S0

    An early-stage research compound with no approval, so it’s an S0 substance.218256465

  • PE-22-28 (Mini-Spadin)S0

    An early-stage research compound never approved anywhere, so it’s an S0 substance.218256465

  • PinealonS0

    Registered in Russia only as a dietary supplement, not a medicine, so it has no approval as a drug and meets the S0 definition.21825646568

  • PNC-27S0

    An experimental anticancer peptide with no approval or registered trials, so it’s an S0 substance.218256465

  • ProstamaxS0

    One of the Khavinson short peptides, with no medicine approval anywhere we checked, so it meets the S0 definition.218256468

  • RetatrutideS0

    An unapproved drug still in development, which S0’s wording covers. Australia’s anti-doping agency says only that it isn’t named on the list and isn’t approved anywhere. Lilly plans to file for FDA approval in early 2027, which could change its status.23257677

  • SLU-PP-332S0

    An early-stage metabolic research compound, banned at all times either way: under S0 as an unapproved substance in 2026, then by name in S4.4.1 from 2027, which isn’t “specified,” so the default ban is longer.221224365

  • SurvodutideS0

    An experimental glucagon and GLP-1 drug in phase 3 with no approval anywhere, so it fits S0’s “drugs under clinical development.” No anti-doping body has named it.218256478

Unclear: no ruling either way · 3

  • AHK-Cu (Copper Tripeptide-3)

    A cosmetic copper peptide never approved as a drug, which fits S0’s wording. But USADA says most peptides in cosmetics aren’t prohibited, and no anti-doping body has ruled on AHK-Cu or on injecting it.2344

  • GHK-Cu

    USADA lists GHK as a cosmetic peptide that isn’t prohibited and says the rules for peptides don’t depend on how they’re used. But no regulator has approved GHK-Cu as a drug, which fits S0’s wording, and no anti-doping body has ruled on the copper form or on injecting it. FDA cleared a GHK-Cu wound gel as a device in 1996, which isn’t a drug approval.24479

  • SNAP-8

    A cosmetic anti-wrinkle peptide never approved as a drug. S0’s wording could reach it, but USADA says most cosmetic peptides aren’t prohibited, and nobody has ruled on SNAP-8.244

Not banned as a substance · 19

  • CerebrolysinIV limit applies

    A registered medicine outside the US that fits no WADA class, so the substance isn’t banned. But its 10–50 mL doses are given as diluted IV drips, and more than 100 mL in 12 hours outside hospital care breaks the IV rule.21880818283

  • DSIP

    Russia registers DSIP as the medicine Deltaran, so S0 shouldn’t apply, and it fits no other class. WADA and USADA haven’t commented, and FDA’s 2026 review said it found no registration anywhere.218838485

  • Fat Blaster

    Its usual ingredients, such as carnitine, methionine, inositol, choline and B vitamins, aren’t on the list. The risks are undeclared extras and drips: a 1 mL shot is fine, but more than 100 mL by IV in 12 hours breaks the IV rule.23182586

  • GlutathioneIV limit applies

    An approved medicine in Italy and Russia that fits no WADA class, so the substance is allowed. A wellness drip of more than 100 mL in 12 hours, outside hospital care, breaks the IV rule.21819258387

  • L-CarnitineIV limit applies

    An FDA-approved medicine that fits no WADA class, so the substance is allowed. A drip of more than 100 mL in 12 hours outside hospital care breaks the IV rule.2258386

  • Lipo-C

    Its usual nutrient ingredients aren’t on the list. Formulas vary, so the risks are undeclared extras and drips of more than 100 mL in 12 hours. A small shot isn’t a problem.231825

  • Mazdutide

    Approved in China, and GLP-1-type drugs aren’t prohibited, so it isn’t banned. WADA doesn’t even monitor it.49208889

  • Melanotan I

    Afamelanotide is an approved medicine, in the EU since 2014 and the US since 2019, and fits no WADA class, so it isn’t banned. Unregulated “Melanotan 1” vials are a quality risk, not an S0 issue.2259091

  • NAD+IV limit applies

    NAD+ isn’t on the list and is an approved medicine in China, so S0 shouldn’t apply. But it’s widely sold as a drip at wellness clinics, and more than 100 mL in 12 hours outside hospital care breaks the IV rule.2258792

  • Orforglipron / Foundayo

    An FDA-approved GLP-1 pill, and GLP-1 drugs aren’t prohibited in sport, so no exemption is needed.452526

  • Oxytocin

    An approved hormone that isn’t among WADA’s banned peptide hormones, so it isn’t banned.2258393

  • PT-141

    Bremelanotide is FDA-approved and fits no WADA class, so it isn’t banned. Its unapproved relative, Melanotan II, falls under S0.22594

  • Selank

    A registered medicine in Russia that fits no WADA class, and Russia’s anti-doping agency lists it as permitted, so it isn’t banned.2188395

  • SemaglutideMonitored by WADA

    Not prohibited in 2026 or 2027, but WADA monitors athletes’ samples for it and is studying whether to ban it.459258396

  • Semax

    A registered medicine in Russia, rated permitted by Russia’s anti-doping agency and not one of the listed corticotropins, so it isn’t banned. Modified versions such as NA-Semax-amidate fall under S0.218839798

  • SS-31

    FDA approval in 2025 took elamipretide out of S0, and it fits no WADA class, so it isn’t banned.22599

  • Thymosin alpha-1

    Approved in Italy and China, and it isn’t the banned thymosin beta-4, so it isn’t prohibited.21825100101

  • TirzepatideMonitored by WADA

    FDA-approved as Mounjaro and Zepbound. Not prohibited in 2026 or 2027, but WADA monitors athletes’ samples for it.459102

  • VIP

    Its synthetic form, aviptadil, is approved in Europe in Invicorp, an injection for erectile dysfunction, so S0 shouldn’t apply, and it fits no other class. No anti-doping body has ruled on VIP itself.2103

A guide, not a ruling. WADA can add a substance or rule on one at any time, and the list changes every January 1.

Sources

Rules and cases come straight from WADA, USADA, the NCAA and the Department of Defense. Tap a number anywhere on this page to see its source.

All sources103
  1. USADA: Nicholas Pierce Accepts Doping Sanction (15 Oct 2024)Anti-doping agency · 2024(opens in a new tab)
  2. World Anti-Doping Code International Standard: Prohibited List 2026Sports regulator · 2025(opens in a new tab)
  3. WADA: The Prohibited List (searchable list and Q&A)Sports regulator · 2026(opens in a new tab)
  4. The 2026 Monitoring ProgramSports regulator · 2025(opens in a new tab)
  5. USADA: Weight Loss Drugs: What athletes need to know about GLP-1sAnti-doping agency · 2026(opens in a new tab)
  6. Eli Lilly: What to know about retatrutide (last updated September 2026)Company report · 2026(opens in a new tab)
  7. Global DRO: About Global DROAnti-doping agency · 2026(opens in a new tab)
  8. USADA: Cortney Casey Accepts Doping Sanction (14 Sep 2023)Anti-doping agency · 2023(opens in a new tab)
  9. WADA publishes 2027 Prohibited List (news release, 21 Sep 2026)Sports regulator · 2026(opens in a new tab)
  10. Francis GL et al. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I... J Mol Endocrinol 1992;8:213-23Study · 1992(opens in a new tab)
  11. Dominikowski A et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis. Front Endocrinol 2026;17:1822475Review · 2026(opens in a new tab)
  12. Summary of Major Modifications and Explanatory Notes: 2025 Prohibited ListSports regulator · 2024(opens in a new tab)
  13. Summary of Major Modifications and Explanatory Notes: 2022 Prohibited ListSports regulator · 2021(opens in a new tab)
  14. Drugs@FDA: GENOTROPIN (somatropin), BLA 020280Regulator · 2026(opens in a new tab)
  15. Drugs@FDA: EGRIFTA (tesamorelin), BLA 022505Regulator · 2026(opens in a new tab)
  16. Drugs@FDA: PREGNYL (chorionic gonadotropin), BLA 017692Regulator · 2026(opens in a new tab)
  17. Drugs@FDA: DEPO-TESTOSTERONE (testosterone cypionate), ANDA 085635Regulator · 2026(opens in a new tab)
  18. State Register of Medicinal Products (GRLS), Ministry of Health of the Russian Federation: full register export dated 16 October 2026Regulator · 2026(opens in a new tab)
  19. TATIONIL (glutatione), AIC 026185049: AIFA database record and SmPC (Italy)Regulator · 2026(opens in a new tab)
  20. Innovent announces mazdutide received approval from China's NMPA for chronic weight management (PR Newswire via BioSpace, 27 June 2025)Company report · 2025(opens in a new tab)
  21. World Anti-Doping Code International Standard: Prohibited List 2027Sports regulator · 2026(opens in a new tab)
  22. Summary of Major Modifications and Explanatory Notes: 2027 Prohibited ListSports regulator · 2026(opens in a new tab)
  23. USADA: Research Chemicals: A Worrying Trend Putting Athletes at RiskAnti-doping agency · 2026(opens in a new tab)
  24. The 2024 Monitoring ProgramSports regulator · 2023(opens in a new tab)
  25. Drugs@FDA via openFDA (dataset updated 16 October 2026)Regulator · 2026(opens in a new tab)
  26. FOUNDAYO (orforglipron) prescribing information, openFDA label record (effective 29 July 2026)Label · 2026(opens in a new tab)
  27. USADA: Aleia Hobbs Accepts Doping Sanction (21 Aug 2026)Anti-doping agency · 2026(opens in a new tab)
  28. International Standard for Therapeutic Use Exemptions (ISTUE) 2023Sports regulator · 2022(opens in a new tab)
  29. WADA: Therapeutic Use Exemptions (athletes and support personnel)Sports regulator · 2026(opens in a new tab)
  30. USADA: Therapeutic Use Exemptions (TUEs)Anti-doping agency · 2026(opens in a new tab)
  31. USADA: BPC-157: What Athletes Should Know About the Prohibited Experimental PeptideAnti-doping agency · 2026(opens in a new tab)
  32. NCAA: Medical Exceptions for NCAA Banned SubstancesSports regulator · 2026(opens in a new tab)
  33. USADA: Independent Arbitrator Imposes Doping Sanction for Kamryn Lute (22 Aug 2024)Anti-doping agency · 2024(opens in a new tab)
  34. USADA: Anthony McCauley Accepts Doping Sanction (17 Sep 2025)Anti-doping agency · 2025(opens in a new tab)
  35. USADA: Joshua Phillips Accepts Doping Sanction (20 Feb 2026)Anti-doping agency · 2026(opens in a new tab)
  36. USADA: Raquel Pennington Accepts Doping Sanction (28 Jan 2021)Anti-doping agency · 2021(opens in a new tab)
  37. USADA: Scott Hisaka Accepts Doping Sanction (5 Jan 2021)Anti-doping agency · 2021(opens in a new tab)
  38. USADA: Arbitrator Imposes Two-Year Sanction on Gilbert Melendez (27 Jul 2020)Anti-doping agency · 2020(opens in a new tab)
  39. USADA: Abdelmounaim Harroufi Receives Doping Sanction (8 Dec 2017)Anti-doping agency · 2017(opens in a new tab)
  40. USADA: Yoel Romero Accepts Doping Sanction (4 Apr 2016)Anti-doping agency · 2016(opens in a new tab)
  41. CAS media release: WADA appeal against 34 current and former players of Essendon Football Club upheldSports tribunal · 2016(opens in a new tab)
  42. WADA Director General Statement on Australian Football League Anti-Doping Tribunal DecisionSports regulator · 2015(opens in a new tab)
  43. USADA: Athlete Advisory: What's New on the 2027 WADA Prohibited List?Anti-doping agency · 2026(opens in a new tab)
  44. USADA: Peptides and Growth Factors in Cosmetics: Are They Banned?Anti-doping agency · 2026(opens in a new tab)
  45. 2026-27 NCAA Banned Substances (PDF)Sports regulator · 2026(opens in a new tab)
  46. OPSS: DoD Prohibited Dietary Supplement Ingredients (searchable list)Government · 2026(opens in a new tab)
  47. OPSS: BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness ProductsGovernment · 2025(opens in a new tab)
  48. Dahan A et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss... Mol Med 2013;19:334-45Study · 2013(opens in a new tab)
  49. Brines M et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med 2015;20:658-66Study · 2015(opens in a new tab)
  50. Bitto A et al. Activation of the EPOR-beta common receptor complex by cibinetide ameliorates impaired wound healing in mice with genetic diabetes. Biochim Biophys Acta 2018;1864:632-639Study · 2018(opens in a new tab)
  51. Thomas A et al. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection... J Sep Sci 2016;39:333-41Study · 2016(opens in a new tab)
  52. Thomas A et al. Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports. Drug Test Anal 2017;9:1799-1803Study · 2017(opens in a new tab)
  53. Henninge J et al. Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test Anal 2010;2:647-50Study · 2010(opens in a new tab)
  54. USADA: Vahe Aivazian Accepts Doping Sanction (15 Apr 2021)Anti-doping agency · 2021(opens in a new tab)
  55. USADA: 6 Things to Know About Peptide Hormones and Releasing FactorsAnti-doping agency · 2026(opens in a new tab)
  56. USADA: David Branch Receives Doping Sanction (18 Sep 2019)Anti-doping agency · 2019(opens in a new tab)
  57. Summary of Major Modifications and Explanatory Notes: 2024 Prohibited ListSports regulator · 2023(opens in a new tab)
  58. USADA: Screen Your Dietary SupplementsAnti-doping agency · 2026(opens in a new tab)
  59. Drugs@FDA: GEREF (sermorelin), NDA 019863Regulator · 2026(opens in a new tab)
  60. World Anti-Doping Code 2021Sports regulator · 2021(opens in a new tab)
  61. Saniona: Update on tesofensine application (12 November 2024)Company report · 2024(opens in a new tab)
  62. Saniona publishes its interim report for the first quarter of 2026 (26 May 2026)Company report · 2026(opens in a new tab)
  63. Saniona publishes its interim report for the second quarter of 2026 (27 August 2026)Company report · 2026(opens in a new tab)
  64. AIFA Banca Dati Farmaci search API (Italy), name searches of 16 October 2026Regulator · 2026(opens in a new tab)
  65. ClinicalTrials.gov NCT01262664: first-in-man phase 1 study of prohibitin-targeting peptide 1 (adipotide)Government · 2012(opens in a new tab)
  66. Novo Nordisk Capital Markets Day 2026: obesity presentationCompany report · 2026(opens in a new tab)
  67. Rospotrebnadzor register of state registration certificates (EAEU), Russian part, valid documents as of 16 October 2026Regulator · 2026(opens in a new tab)
  68. Benoist CC et al. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. J Pharmacol Exp Ther 2014;351(2):390-402 (retracted 2025)Study · 2014 · Expression of concern(opens in a new tab)
  69. ClinicalTrials.gov NCT07321886: A study of eloralintide (LY3841136) in obesity or overweight without type 2 diabetes (phase 3, Eli Lilly)Government · 2026(opens in a new tab)
  70. FDA Briefing Document: Epitalon-related bulk drug substances (PCAC, July 2026)Regulator · 2026(opens in a new tab)
  71. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee (FDA)Regulator · 2026(opens in a new tab)
  72. FDA Briefing Document: KPV-related bulk drug substances (PCAC, July 2026)Regulator · 2026(opens in a new tab)
  73. Promore Pharma: phase IIb results of ropocamptide (LL-37) in venous leg ulcers (19 November 2020)Company report · 2020(opens in a new tab)
  74. ClinicalTrials.gov NCT07437560: Melanotan II as an adjunct to NB-UVB phototherapy in vitiligo (phase 2, China)Government · 2026(opens in a new tab)
  75. Lilly's triple agonist retatrutide successful in two additional Phase 3 obesity trials (PR Newswire via BioSpace, 23 July 2026)Company report · 2026(opens in a new tab)
  76. Retatrutide (Reta) explained, Sport Integrity Australia (archived June 8, 2026)Sports regulator · 2026(opens in a new tab)
  77. Zealand Pharma company announcement No. 52/2026: survodutide SYNCHRONIZE-2 results (GlobeNewswire via Taiwan News, 1 October 2026)Company report · 2026(opens in a new tab)
  78. FDA 510(k) K953853: IAMIN Gel Wound Dressing (ProCyte), openFDA device recordRegulator · 1996(opens in a new tab)
  79. Cerebrolysin, Vidal Russia drug referenceLabel · 2025(opens in a new tab)
  80. EVER Pharma: Innovation page (Cerebrolysin)Company report · 2026(opens in a new tab)
  81. Cerebrolysin.com (EVER Pharma)Company report · 2026(opens in a new tab)
  82. RUSADA medicine-status database (list.rusada.ru), records dated 12 October 2026Sports regulator · 2026(opens in a new tab)
  83. Deltaran, Vidal Russia drug referenceLabel · 2026(opens in a new tab)
  84. FDA Briefing Document: emideltide-related bulk drug substances (PCAC, July 2026)Regulator · 2026(opens in a new tab)
  85. CARNITOR (levocarnitine) tablets and oral solution prescribing information, openFDA label record (effective 23 January 2024)Label · 2024(opens in a new tab)
  86. IV Infusions: Explanatory Note (USADA, updated 14 July 2026)Sports regulator · 2026(opens in a new tab)
  87. Innovent announces mazdutide received approval from China's NMPA for glycemic control in adults with type 2 diabetes (PR Newswire via BioSpace, 19 September 2025)Company report · 2025(opens in a new tab)
  88. Mazdutide approved for marketing (National Business Daily via Sina Finance, 28 June 2025)News · 2025(opens in a new tab)
  89. Scenesse (afamelanotide): EPAR overview, European Medicines AgencyRegulator · 2014(opens in a new tab)
  90. SCENESSE (afamelanotide) prescribing information, openFDA label record (effective 11 May 2026)Label · 2026(opens in a new tab)
  91. 'NAD+ anti-aging shot' is a gimmick: China has never approved any anti-aging indication (CCTV News via Guangming Online, 6 September 2026)News · 2026(opens in a new tab)
  92. PITOCIN (oxytocin injection) prescribing information, openFDA label record (effective 6 May 2026)Label · 2026(opens in a new tab)
  93. VYLEESI (bremelanotide) prescribing information, openFDA label record (effective 13 November 2025)Label · 2025(opens in a new tab)
  94. Selank 0.15% nasal drops, Vidal Russia drug referenceLabel · 2025(opens in a new tab)
  95. The 2027 Monitoring Program (WADA)Sports regulator · 2027(opens in a new tab)
  96. Semax 0.1% nasal drops, Vidal Russia drug referenceLabel · 2025(opens in a new tab)
  97. FDA Briefing Document: Semax-related bulk drug substances (PCAC, July 2026)Regulator · 2026(opens in a new tab)
  98. FORZINITY (elamipretide) prescribing information, openFDA label record (effective 10 December 2025)Label · 2025(opens in a new tab)
  99. ZADAXIN (timosina alfa 1), AIC 028364026: AIFA database record and SmPC (Italy)Regulator · 2026(opens in a new tab)
  100. SciClone Pharmaceuticals Form 10-K for fiscal 2016 (SEC)Company report · 2017(opens in a new tab)
  101. ZEPBOUND (tirzepatide) injection - Prescribing Information and Medication Guide (Revised 8/2026; DailyMed SPL v40, published Sep 2, 2026)Drug label · 2026(opens in a new tab)
  102. INVICORP 25 microgrammes/2 mg, solution injectable: summary of product characteristics (ANSM, France)Regulator · 2018(opens in a new tab)
Source

Keep reading